As the U.S. market navigates through a period of volatility fueled by recent tariff announcements, investors are keeping a keen eye on companies that can withstand economic headwinds. In this environment, growth stocks with high insider ownership often stand out as they suggest strong confidence from those closest to the company, potentially offering resilience and alignment with shareholder interests.

Top 10 Growth Companies With High Insider Ownership In The United States

Name Insider Ownership Earnings Growth Super Micro Computer (NasdaqGS:SMCI) 14.2% 29.8% Hims & Hers Health (NYSE:HIMS) 13.2% 21.8% Duolingo (NasdaqGS:DUOL) 14.4% 37.3% Coastal Financial (NasdaqGS:CCB) 14.5% 46.3% Astera Labs (NasdaqGS:ALAB) 15.9% 61.3% Clene (NasdaqCM:CLNN) 19.5% 63.1% FTC Solar (NasdaqCM:FTCI) 31.6% 62.2% BBB Foods (NYSE:TBBB) 16.2% 34.5% Upstart Holdings (NasdaqGS:UPST) 12.7% 100.1% Credit Acceptance (NasdaqGS:CACC) 14.4% 33.9%

Click here to see the full list of 204 stocks from our Fast Growing US Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

ARS Pharmaceuticals

Simply Wall St Growth Rating: ★★★★★☆

Overview: ARS Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for severe allergic reactions with a market cap of $1.23 billion.

Operations: The company's revenue is primarily derived from its pharmaceuticals segment, which generated $89.15 million.

Insider Ownership: 19%

Return On Equity Forecast: N/A (2027 estimate)

ARS Pharmaceuticals is experiencing significant growth, with earnings projected to increase 54.8% annually, outpacing the US market. The company recently became profitable, reporting a net income of US$8 million for 2024. Revenue surged to US$89.15 million from just US$0.03 million the previous year, driven by FDA approval of neffy, an innovative needle-free epinephrine nasal spray for allergic reactions. Despite trading below estimated fair value and no recent insider trading activity reported, ARS's strategic expansions and partnerships indicate robust potential for future performance.

Click here to discover the nuances of ARS Pharmaceuticals with our detailed analytical future growth report. Insights from our recent valuation report point to the potential overvaluation of ARS Pharmaceuticals shares in the market.NasdaqGM:SPRY Ownership Breakdown as at Apr 2025

Kaspi.kz

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Joint Stock Company Kaspi.kz, with a market cap of $17.92 billion, offers payments, marketplace, and fintech solutions for consumers and merchants in Kazakhstan, Azerbaijan, and Ukraine.

Story Continues

Operations: The company's revenue segments consist of Fintech at 1.28 billion KZT, Payments at 587.10 million KZT, and Marketplace at 732.94 million KZT.

Insider Ownership: 40%

Return On Equity Forecast: 46% (2027 estimate)

Kaspi.kz's earnings are expected to grow at 15.8% annually, surpassing the US market average. Trading significantly below estimated fair value, Kaspi.kz offers good relative value compared to peers. Recent financial results show substantial revenue and net income growth year-over-year. The company issued US$650 million in notes for general corporate purposes, marking a significant bond issuance from Kazakhstan. Despite no recent insider trading activity and a temporary dividend halt, Kaspi.kz's strategic moves highlight its potential for continued growth.

Get an in-depth perspective on Kaspi.kz's performance by reading our analyst estimates report here. According our valuation report, there's an indication that Kaspi.kz's share price might be on the cheaper side.NasdaqGS:KSPI Ownership Breakdown as at Apr 2025

monday.com

Simply Wall St Growth Rating: ★★★★★☆

Overview: monday.com Ltd. develops software applications across various regions including the United States, Europe, the Middle East, Africa, and the United Kingdom, with a market cap of approximately $13.31 billion.

Operations: The company's revenue segment is primarily derived from Internet Software & Services, totaling $971.99 million.

Insider Ownership: 14.2%

Return On Equity Forecast: 21% (2027 estimate)

monday.com is poised for significant growth, with earnings projected to rise 35.5% annually, outpacing the US market. Despite recent share price volatility, the company has turned profitable and expects substantial revenue growth of 24% to 26% this year. Recent strategic partnerships and product launches enhance its service offerings, while a US$649.57 million shelf registration supports potential expansion initiatives. The company's insider ownership underscores confidence in its long-term prospects amidst evolving digital landscapes.

Click to explore a detailed breakdown of our findings in monday.com's earnings growth report. In light of our recent valuation report, it seems possible that monday.com is trading beyond its estimated value.NasdaqGS:MNDY Earnings and Revenue Growth as at Apr 2025

Key Takeaways

Gain an insight into the universe of 204 Fast Growing US Companies With High Insider Ownership by clicking here. Ready For A Different Approach? Uncover the next big thing with financially sound penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include NasdaqGM:SPRYNasdaqGS:KSPI and NasdaqGS:MNDY.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments